Withings adds AFib Watch to their Product Line
Withings, pioneer of the digital health movement and connected analogue watches, unveiled its ScanWatch, a clinically validated hybrid smartwatch to detect both risk of arrhythmia (AFib) and sleep apnea – all from the wrist. Helping users and their physicians monitor overall health with a smartwatch that identifies highly prevalent cardiovascular and sleep issues early.
Worn throughout the day and night, ScanWatch can provide an early warning system, collecting and sharing critical health data.
Although not a new capability in a smart watch/smartphone combination, it does increase the availability of AFib watches to most consumers from the top MHealth brands. The real groundbreaker in this area was AliveCor who later merged with and incorporated the capability into OMRON’s watches. The latest version of Apple Watch now includes the capability as well. This all bodes well for the wellness/preemptive healthcare area for consumers. Giving early warning of conditions and acquiring important ECG data for personal early warning/physician diagnosis plus a database for further analysis across consumer sectors. Through continuous monitoring of heart rate and detection of irregular heartbeat,the user can then take an ECG reading and in just 30 seconds get a more in depth analysis and storing of both data and initial determination for further action.